NumerixS Investment Technologies’s Cantel Medical Corporation CMD Stock Holding History

NumerixS Investment Technologies’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,200	Closed	-$97K	–	998
2020 Q2	$97K	Sell	2,200 -3,200	-59%	-$119K	0.03%	598
2020 Q1	$194K	Buy	+5,400	New	+$307K	0.1%	254
2018 Q4	–	Sell	-2,200	Closed	-$206K	–	1496
2018 Q3	$206K	Buy	+2,200	New	+$210K	0.04%	576
2018 Q2	–	Sell	-1,300	Closed	-$144K	–	1427
2018 Q1	$144K	Buy	1,300 +100	+8%	+$11.2K	0.04%	529
2017 Q4	$123K	Buy	1,200 +200	+20%	+$19.9K	0.03%	620
2017 Q3	$94K	Buy	1,000 +900	+900%	+$71K	0.02%	773
2017 Q2	$8K	Buy	+100	New	+$7.51K	﹤0.01%	1070
2017 Q1	–	Sell	-3,500	Closed	-$276K	–	1452
2016 Q4	$276K	Sell	3,500 -2,200	-39%	-$171K	0.03%	572
2016 Q3	$444K	Buy	+5,700	New	+$414K	0.06%	411

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NumerixS Investment Technologies's CMD Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 2,200 shares — an estimated $97K sold.

NumerixS Investment Technologies first reported a position in CMD in Q3 2016 and held it in 9 quarters. The position peaked at $444K in Q3 2016. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

NumerixS Investment Technologies reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 2,200 Cantel Medical Corporation shares in Q3 2020, an estimated $97K.
NumerixS Investment Technologies first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 9 quarters.
NumerixS Investment Technologies's Cantel Medical Corporation position peaked at $444K in Q3 2016.
196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.